Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments, Enzymes, Services), By Technology(Histone Methylation), By Application (Oncology, Non-oncology), By End-use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Epigenetics Diagnostics Market Growth & Trends
The global epigenetics diagnostics market is anticipated to reach USD 39.15 billion by 2030 and is anticipated to expand at a CAGR of 15.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to increased investment, funding, and approvals for epigenetics research and development, and the increasing prevalence of MDD (Major Depressive Disorder). According to the World Health Organization (WHO), in 2023, approximately 5% of adults experienced depressive disorders. Furthermore, a study published by the National Center for Biotechnology Information (NCBI) in 2022 reported that around 280 million people worldwide are affected by MDD. Epigenetics' applications in drug discovery and development are growing, and genome sequencing is becoming more affordable. Additionally, advancements in technology related to epigenetic drug discovery contribute to this growth.
Additionally, an increase in investment from both public and private organizations in epigenetics is expected to drive market growth from 2023 to 2030. In February 2025, TruDiagnostic introduced the grant, which provides USD 400,000 in funding to support researchers working in DNA methylation, longevity science, and diagnostic innovation. A study published by NCBI in 2022 stated that epigenetic modification plays a crucial role in maintaining cellular homeostasis and the genome and provides information about the cause and development of virus infection.
Epigenetics Diagnostics Market Report Highlights
Hoffmann- La Roche Ltd.
Thermo Fisher Scientific, Inc.
Eisai Co. Ltd.
Novartis AG
Element Biosciences, Inc.
Cantata Bio (Dovetail Genomics LLC.)
Illumina, Inc.
ValiRx Plc.
Abcam Ltd.
Epigenetics Diagnostics Market Growth & Trends
The global epigenetics diagnostics market is anticipated to reach USD 39.15 billion by 2030 and is anticipated to expand at a CAGR of 15.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to increased investment, funding, and approvals for epigenetics research and development, and the increasing prevalence of MDD (Major Depressive Disorder). According to the World Health Organization (WHO), in 2023, approximately 5% of adults experienced depressive disorders. Furthermore, a study published by the National Center for Biotechnology Information (NCBI) in 2022 reported that around 280 million people worldwide are affected by MDD. Epigenetics' applications in drug discovery and development are growing, and genome sequencing is becoming more affordable. Additionally, advancements in technology related to epigenetic drug discovery contribute to this growth.
Additionally, an increase in investment from both public and private organizations in epigenetics is expected to drive market growth from 2023 to 2030. In February 2025, TruDiagnostic introduced the grant, which provides USD 400,000 in funding to support researchers working in DNA methylation, longevity science, and diagnostic innovation. A study published by NCBI in 2022 stated that epigenetic modification plays a crucial role in maintaining cellular homeostasis and the genome and provides information about the cause and development of virus infection.
Epigenetics Diagnostics Market Report Highlights
- Reagents dominated the product segment with more than 30.0% share in 2024, owing to their high usage in epigenetic research studies.
- The DNA Methylation segment is expected to grow at the fastest CAGR of 44.5% over the forecast period 2025 – 2030.
- The oncology segment held the largest market share in 2024, and with the increasing incidence of cancer, the epigenetic market is expected to grow over the forecast period.
- The academic research segment held the largest market share in 2024. The growth is attributed to the factors such as increased funding for research and development by various companies and supportive initiatives from the government.
- North America led the epigenetic diagnostics market in 2024 due to the presence of key market players and an advanced healthcare infrastructure. Additionally, increasing awareness along with significant R&D expenditure is expected to fuel growth throughout the forecast period.
Hoffmann- La Roche Ltd.
Thermo Fisher Scientific, Inc.
Eisai Co. Ltd.
Novartis AG
Element Biosciences, Inc.
Cantata Bio (Dovetail Genomics LLC.)
Illumina, Inc.
ValiRx Plc.
Abcam Ltd.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Technology
2.2.3. Application
2.2.4. End Use
2.2.5. Regional outlook
2.3. Competitive Insights
CHAPTER 3. EPIGENETICS DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Epigenetics Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Epigenetics Diagnostics Market: Pipeline Analysis
CHAPTER 4. EPIGENETICS DIAGNOSTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Epigenetics Diagnostics Market: Product Movement Analysis
4.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Reagents
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Kits
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. ChIP Sequencing Kit
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Whole Genomic Amplification kit
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Bisulfite Conversion kit
4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. RNA Sequencing kit
4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Others
4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million
4.6. Instruments
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Enzymes
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Services
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. EPIGENETICS DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Technology Segment Dashboard
5.2. Epigenetics Diagnostics Market: Technology Movement Analysis
5.3. Epigenetics Diagnostics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. DNA Methylation
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Reagents
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Kits
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Instruments
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Enzymes
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Services
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Histone Methylation
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Reagents
5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. Kits
5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Instruments
5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. Enzymes
5.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Services
5.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Histone Acetylation
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Reagents
5.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. Kits
5.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Instruments
5.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. Enzymes
5.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Services
5.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Large non - coding RNA
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Reagents
5.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. Kits
5.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Instruments
5.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.5. Enzymes
5.7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.6. Services
5.7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MicroRNA modification
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Reagents
5.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. Kits
5.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.4. Instruments
5.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.5. Enzymes
5.8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.6. Services
5.8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Chromatin structure
5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.2. Reagents
5.9.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.3. Kits
5.9.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.4. Instruments
5.9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.5. Enzymes
5.9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.6. Services
5.9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. EPIGENETICS DIAGNOSTICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Application Segment Dashboard
6.2. Epigenetics Diagnostics Market: Application Movement Analysis
6.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Oncology
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Solid tumors
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Liquid tumors
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Non - Oncology
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Inflammatory diseases
6.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Metabolic diseases
6.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Infectious diseases
6.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Cardiovascular diseases
6.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Others
6.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. EPIGENETICS DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Application Segment Dashboard
7.2. Epigenetics Diagnostics Market: End Use Movement Analysis
7.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Academic Research
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Clinical Research
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Hospitals & Clinics
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Pharmaceutical & Biotechnology Companies
7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Other Users
7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. EPIGENETICS DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Continuous bioprocessing market by Region: Key Takeaways
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Denmark
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Norway
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework/ reimbursement structure
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework/ reimbursement structure
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Key company heat map analysis, 2024
9.4. Company Profiles
9.4.1. Hoffmann- La Roche Ltd.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Thermo Fisher Scientific, Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Eisai Co. Ltd.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Novartis AG
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Element Bisosciences, Inc.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Cantata Bio (Dovetail Genomics LLC.)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Illumina, Inc.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. ValiRx Plc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Abcam Ltd.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Technology
2.2.3. Application
2.2.4. End Use
2.2.5. Regional outlook
2.3. Competitive Insights
CHAPTER 3. EPIGENETICS DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Epigenetics Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Epigenetics Diagnostics Market: Pipeline Analysis
CHAPTER 4. EPIGENETICS DIAGNOSTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Epigenetics Diagnostics Market: Product Movement Analysis
4.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Reagents
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Kits
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. ChIP Sequencing Kit
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Whole Genomic Amplification kit
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Bisulfite Conversion kit
4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. RNA Sequencing kit
4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Others
4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million
4.6. Instruments
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Enzymes
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Services
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. EPIGENETICS DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Technology Segment Dashboard
5.2. Epigenetics Diagnostics Market: Technology Movement Analysis
5.3. Epigenetics Diagnostics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. DNA Methylation
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Reagents
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Kits
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Instruments
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Enzymes
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Services
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Histone Methylation
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Reagents
5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. Kits
5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Instruments
5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. Enzymes
5.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Services
5.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Histone Acetylation
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Reagents
5.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. Kits
5.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Instruments
5.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. Enzymes
5.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Services
5.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Large non - coding RNA
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Reagents
5.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. Kits
5.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Instruments
5.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.5. Enzymes
5.7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7.6. Services
5.7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MicroRNA modification
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Reagents
5.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. Kits
5.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.4. Instruments
5.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.5. Enzymes
5.8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8.6. Services
5.8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Chromatin structure
5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.2. Reagents
5.9.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.3. Kits
5.9.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.4. Instruments
5.9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.5. Enzymes
5.9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9.6. Services
5.9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. EPIGENETICS DIAGNOSTICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Application Segment Dashboard
6.2. Epigenetics Diagnostics Market: Application Movement Analysis
6.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Oncology
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Solid tumors
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Liquid tumors
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Non - Oncology
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Inflammatory diseases
6.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Metabolic diseases
6.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Infectious diseases
6.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Cardiovascular diseases
6.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Others
6.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. EPIGENETICS DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Application Segment Dashboard
7.2. Epigenetics Diagnostics Market: End Use Movement Analysis
7.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Academic Research
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Clinical Research
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Hospitals & Clinics
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Pharmaceutical & Biotechnology Companies
7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Other Users
7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. EPIGENETICS DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Continuous bioprocessing market by Region: Key Takeaways
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Denmark
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Norway
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework/ reimbursement structure
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework/ reimbursement structure
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Key company heat map analysis, 2024
9.4. Company Profiles
9.4.1. Hoffmann- La Roche Ltd.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Thermo Fisher Scientific, Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Eisai Co. Ltd.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Novartis AG
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Element Bisosciences, Inc.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Cantata Bio (Dovetail Genomics LLC.)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Illumina, Inc.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. ValiRx Plc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Abcam Ltd.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 Epigenetics Diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 Global epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 Global epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 Global epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 Global epigenetics diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 North America epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 North America epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 North America epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 North America epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 North America epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 12 U.S. epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Mexico epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Mexico epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 25 Europe epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 26 Europe epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 Europe epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 28 Europe epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 Germany epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 Germany epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 32 Germany epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 UK epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 UK epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35 UK epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36 UK epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 France epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 France epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39 France epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 40 France epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Italy epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44 Italy epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Spain epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47 Spain epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48 Spain epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 51 Denmark epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Sweden epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Sweden epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Norway epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Norway epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 Norway epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Norway epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 62 Asia Pacific epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63 Asia Pacific epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64 Asia Pacific epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 65 Asia Pacific epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 66 China epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 67 China epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 68 China epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 69 China epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 70 Japan epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 Japan epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 72 Japan epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 73 Japan epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 74 India epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 75 India epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 76 India epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 77 India epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 78 South Korea epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 79 South Korea epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 80 South Korea epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 81 South Korea epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 82 Australia epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 83 Australia epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 84 Australia epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 Australia epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 87 Thailand epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 88 Thailand epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 92 Latin America epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 96 Brazil epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 97 Brazil epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 100 Argentina epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA epigenetics diagnostics market, by region, 2018 - 2030 (USD Million)
Table 104 MEA epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 105 MEA epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 106 MEA epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 109 South Africa epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 117 UAE epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 118 UAE epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 121 Kuwait epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 Epigenetics Diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 Global epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 Global epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 Global epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 Global epigenetics diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 North America epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 North America epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 North America epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 North America epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 North America epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 12 U.S. epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Mexico epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Mexico epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 25 Europe epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 26 Europe epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 Europe epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 28 Europe epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 Germany epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 Germany epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 32 Germany epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 UK epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 UK epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35 UK epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36 UK epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 France epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 France epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39 France epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 40 France epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Italy epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44 Italy epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Spain epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47 Spain epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48 Spain epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 51 Denmark epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Sweden epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Sweden epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Norway epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Norway epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 Norway epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Norway epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 62 Asia Pacific epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63 Asia Pacific epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64 Asia Pacific epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 65 Asia Pacific epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 66 China epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 67 China epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 68 China epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 69 China epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 70 Japan epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 Japan epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 72 Japan epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 73 Japan epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 74 India epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 75 India epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 76 India epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 77 India epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 78 South Korea epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 79 South Korea epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 80 South Korea epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 81 South Korea epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 82 Australia epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 83 Australia epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 84 Australia epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 Australia epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 87 Thailand epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 88 Thailand epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 92 Latin America epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 96 Brazil epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 97 Brazil epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 100 Argentina epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA epigenetics diagnostics market, by region, 2018 - 2030 (USD Million)
Table 104 MEA epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 105 MEA epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 106 MEA epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 109 South Africa epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 117 UAE epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 118 UAE epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 121 Kuwait epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Epigenetics diagnostics market: market outlook
Fig. 10 Epigenetics diagnostics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Epigenetics diagnostics market driver impact
Fig. 16 Epigenetics diagnostics market restraint impact
Fig. 17 Epigenetics diagnostics market strategic initiatives analysis
Fig. 18 Epigenetics diagnostics market: Technology movement analysis
Fig. 19 Epigenetics diagnostics market: Technology outlook and key takeaways
Fig. 20 DNA methylation market estimates and forecast, 2018 - 2030
Fig. 21 Histone methylation estimates and forecast, 2018 - 2030
Fig. 22 Histone acetylation market estimates and forecast, 2018 - 2030
Fig. 23 Large non - coding RNA estimates and forecast, 2018 - 2030
Fig. 24 MircoRNA modification market estimates and forecast, 2018 - 2030
Fig. 25 Chromatin structures estimates and forecast, 2018 - 2030
Fig. 26 Epigenetics diagnostics market: Product movement analysis
Fig. 27 Epigenetics diagnostics market: Product outlook and key takeaways
Fig. 28 Reagents market estimates and forecasts, 2018 - 2030
Fig. 29 Kits market estimates and forecasts,2018 - 2030
Fig. 30 ChIP Sequencing kit market estimates and forecasts,2018 - 2030
Fig. 31 Whole Genomic Amplification kit market estimates and forecasts,2018 - 2030
Fig. 32 Bisulfite Conversion kit market estimates and forecasts,2018 - 2030
Fig. 33 RNA Sequencing kit market estimates and forecasts,2018 - 2030
Fig. 34 Others market estimates and forecasts,2018 - 2030
Fig. 35 Instruments market estimates and forecasts,2018 - 2030
Fig. 36 Enzymes market estimates and forecasts,2018 - 2030
Fig. 37 Service market estimates and forecasts,2018 - 2030
Fig. 38 Epigenetics diagnostics market: Application movement analysis
Fig. 39 Epigenetics diagnostics market: Application outlook and key takeaways
Fig. 40 Oncology market estimates and forecasts, 2018 - 2030
Fig. 41 Solid tumors market estimates and forecasts, 2018 - 2030
Fig. 42 Liquid tumors market estimates and forecasts, 2018 - 2030
Fig. 43 Non - oncology market estimates and forecasts,2018 - 2030
Fig. 44 Inflammatory diseases market estimates and forecasts, 2018 - 2030
Fig. 45 Metabolic diseases market estimates and forecasts, 2018 - 2030
Fig. 46 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 47 Cardiovascular diseases market estimates and forecasts, 2018 - 2030
Fig. 48 Others market estimates and forecasts, 2018 - 2030
Fig. 49 Epigenetics diagnostics market: End use movement analysis
Fig. 50 Epigenetics diagnostics market: End use outlook and key takeaways
Fig. 51 Academic research market estimates and forecasts, 2018 - 2030
Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030
Fig. 53 Hospitals & clinics market estimates and forecasts, 2018 - 2030
Fig. 54 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 55 Other users market estimates and forecasts, 2018 - 2030
Fig. 56 Global epigenetics diagnostics market: Regional movement analysis
Fig. 57 Global epigenetics diagnostics market: Regional outlook and key takeaways
Fig. 58 North America market estimates and forecasts, 2018 - 2030
Fig. 59 U.S. market estimates and forecasts, 2018 - 2030
Fig. 60 Canada market estimates and forecasts, 2018 - 2030
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Europe market estimates and forecasts, 2018 - 2030
Fig. 63 UK market estimates and forecasts, 2018 - 2030
Fig. 64 Germany market estimates and forecasts, 2018 - 2030
Fig. 65 France market estimates and forecasts, 2018 - 2030
Fig. 66 Italy market estimates and forecasts, 2018 - 2030
Fig. 67 Spain market estimates and forecasts, 2018 - 2030
Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
Fig. 70 Norway market estimates and forecasts, 2018 - 2030
Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 72 China market estimates and forecasts, 2018 - 2030
Fig. 73 Japan market estimates and forecasts, 2018 - 2030
Fig. 74 India market estimates and forecasts, 2018 - 2030
Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
Fig. 77 Latin America market estimates and forecasts, 2018 - 2030
Fig. 78 Brazil market estimates and forecasts, 2018 - 2030
Fig. 79 Argentina market estimates and forecasts, 2018 - 2030
Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 81 South Africa market estimates and forecasts, 2018 - 2030
Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 83 UAE market estimates and forecasts, 2018 - 2030
Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Epigenetics diagnostics market: market outlook
Fig. 10 Epigenetics diagnostics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Epigenetics diagnostics market driver impact
Fig. 16 Epigenetics diagnostics market restraint impact
Fig. 17 Epigenetics diagnostics market strategic initiatives analysis
Fig. 18 Epigenetics diagnostics market: Technology movement analysis
Fig. 19 Epigenetics diagnostics market: Technology outlook and key takeaways
Fig. 20 DNA methylation market estimates and forecast, 2018 - 2030
Fig. 21 Histone methylation estimates and forecast, 2018 - 2030
Fig. 22 Histone acetylation market estimates and forecast, 2018 - 2030
Fig. 23 Large non - coding RNA estimates and forecast, 2018 - 2030
Fig. 24 MircoRNA modification market estimates and forecast, 2018 - 2030
Fig. 25 Chromatin structures estimates and forecast, 2018 - 2030
Fig. 26 Epigenetics diagnostics market: Product movement analysis
Fig. 27 Epigenetics diagnostics market: Product outlook and key takeaways
Fig. 28 Reagents market estimates and forecasts, 2018 - 2030
Fig. 29 Kits market estimates and forecasts,2018 - 2030
Fig. 30 ChIP Sequencing kit market estimates and forecasts,2018 - 2030
Fig. 31 Whole Genomic Amplification kit market estimates and forecasts,2018 - 2030
Fig. 32 Bisulfite Conversion kit market estimates and forecasts,2018 - 2030
Fig. 33 RNA Sequencing kit market estimates and forecasts,2018 - 2030
Fig. 34 Others market estimates and forecasts,2018 - 2030
Fig. 35 Instruments market estimates and forecasts,2018 - 2030
Fig. 36 Enzymes market estimates and forecasts,2018 - 2030
Fig. 37 Service market estimates and forecasts,2018 - 2030
Fig. 38 Epigenetics diagnostics market: Application movement analysis
Fig. 39 Epigenetics diagnostics market: Application outlook and key takeaways
Fig. 40 Oncology market estimates and forecasts, 2018 - 2030
Fig. 41 Solid tumors market estimates and forecasts, 2018 - 2030
Fig. 42 Liquid tumors market estimates and forecasts, 2018 - 2030
Fig. 43 Non - oncology market estimates and forecasts,2018 - 2030
Fig. 44 Inflammatory diseases market estimates and forecasts, 2018 - 2030
Fig. 45 Metabolic diseases market estimates and forecasts, 2018 - 2030
Fig. 46 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 47 Cardiovascular diseases market estimates and forecasts, 2018 - 2030
Fig. 48 Others market estimates and forecasts, 2018 - 2030
Fig. 49 Epigenetics diagnostics market: End use movement analysis
Fig. 50 Epigenetics diagnostics market: End use outlook and key takeaways
Fig. 51 Academic research market estimates and forecasts, 2018 - 2030
Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030
Fig. 53 Hospitals & clinics market estimates and forecasts, 2018 - 2030
Fig. 54 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 55 Other users market estimates and forecasts, 2018 - 2030
Fig. 56 Global epigenetics diagnostics market: Regional movement analysis
Fig. 57 Global epigenetics diagnostics market: Regional outlook and key takeaways
Fig. 58 North America market estimates and forecasts, 2018 - 2030
Fig. 59 U.S. market estimates and forecasts, 2018 - 2030
Fig. 60 Canada market estimates and forecasts, 2018 - 2030
Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
Fig. 62 Europe market estimates and forecasts, 2018 - 2030
Fig. 63 UK market estimates and forecasts, 2018 - 2030
Fig. 64 Germany market estimates and forecasts, 2018 - 2030
Fig. 65 France market estimates and forecasts, 2018 - 2030
Fig. 66 Italy market estimates and forecasts, 2018 - 2030
Fig. 67 Spain market estimates and forecasts, 2018 - 2030
Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
Fig. 70 Norway market estimates and forecasts, 2018 - 2030
Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 72 China market estimates and forecasts, 2018 - 2030
Fig. 73 Japan market estimates and forecasts, 2018 - 2030
Fig. 74 India market estimates and forecasts, 2018 - 2030
Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
Fig. 77 Latin America market estimates and forecasts, 2018 - 2030
Fig. 78 Brazil market estimates and forecasts, 2018 - 2030
Fig. 79 Argentina market estimates and forecasts, 2018 - 2030
Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 81 South Africa market estimates and forecasts, 2018 - 2030
Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 83 UAE market estimates and forecasts, 2018 - 2030
Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030
